Hepatitis C Screening: From Modeling to Public Health Policy

Clin Infect Dis. 2018 Jan 18;66(3):385-386. doi: 10.1093/cid/cix800.
No abstract available

Keywords: Markov model; cost-effectiveness analysis; decision-analytic modeling; direct-acting antivirals; screening guidelines.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adolescent
  • Antiviral Agents*
  • Cost-Benefit Analysis
  • Health Policy
  • Hepatitis C, Chronic*
  • Humans
  • Mass Screening
  • Primary Health Care
  • Young Adult

Substances

  • Antiviral Agents